US10689446B2ActiveUtilityA1
Recombinant CD74 polypeptides
Assignee: UNIV OREGON HEALTH & SCIENCEPriority: Jun 22, 2016Filed: Jun 21, 2017Granted: Jun 23, 2020
Est. expiryJun 22, 2036(~10 yrs left)· nominal 20-yr term from priority
C07K 14/70539C07K 2319/40C07K 16/2833
48
PatentIndex Score
0
Cited by
8
References
3
Claims
Abstract
Disclosed are recombinant CD74 polypeptides mutated relative to the naturally occurring CD74 polypeptides with improved properties such as binding of CD74 ligands such as MIF and RTL1000 as well as polynucleotides that encode the polypeptides, expression vectors comprising the polynucleotides, bacteria that include the expression vectors, and methods of making the recombinant polypeptides.
Claims
exact text as granted — not AI-modifiedThe invention claimed is:
1. A recombinant polypeptide comprising: the amino acid sequence of SEQ ID NO: 1 or SEQ ID NO: 3.
2. The polypeptide of claim 1 , further comprising a label, the label comprising a fluorescent dye, an enzyme, a protein tag, a fluorescent protein, or biotin.
3. The polypeptide of claim 1 , wherein the polypeptide consists of the amino acid sequence of SEQ ID NO: 1 or SEQ ID NO: 3.Cited by (0)
No later patents cite this yet.
References (0)
No backward citations on record.